HighCape Capital Acquisition Corp.
Status: Deal Closed
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Sep 4, 2020 |
| CEO | Kevin Rakin |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 18 months |
| IPO Sector |
Healthcare
Life sciences and life sciences related industries |
| IPO Geography | Global |
| Target Company | Quantum-Si |
| Deal Announced | Feb 18, 2021 |
| Deal Size, $M | $946.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Jun 9, 2021 |
| Amendment Vote | TBD |
| Closing Date | Jun 10, 2021 |
Formerly CAPA
QSI
QSIAW
| Price | $1.17 |
|---|---|
| Last closing price | $1.14 |
| H/L, today | $1.08 / $1.20 |
| H/L, 52-week | $1.12 / $3.90 |
| Volume, today | 3,092,448 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on HighCape Capital Acquisition Corp. :
- Structure and cap table
- 5 directors & officers
- 23 filings and events
- 1 underwriters
- 4 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Kevin Rakin | 59 | CEO and Chairman |
| Matt Zuga | 55 | CFO, COO and Director |
| David Colpman | 59 | Director |
| Antony Loebel, M.D. | 59 | Director |
| Robert Taub | 73 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Cantor Fitzgerald | BR | 10,000,000 | units |
| 10,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.